Paper · 5387828
Suppression of malignancy by cell fusion.
Harris H and 4 others. Nature, 1969. Cited by 552 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Suppression of malignancy by cell fusion. Papers, record 5387828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5387828
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hybridization, Genetic | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Carcinoma, Ehrlich Tumor | |
| Cell Line | |
| Clone Cells | |
| Culture Media | |
| Culture Techniques | |
| Histocompatibility | |
| Karyotyping | |
| L Cells | |
| Methods | |
| Neoplasm Transplantation | |
| Sarcoma, Experimental | |
| Transplantation Immunology |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by132
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 552 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,168,747 | Genomic Reshuffling After Cell Fusion: Catalyst for Cancer Evolution and Progression. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42168747 | PubMed |
| 41,598,259 | The Roles of the Membrane-Anchored Glycoprotein RECK in Animal Development, Tumor Suppression, and Beyond. | Life (Basel) | 2026 | https://conductscience.org/library/papers/41598259 | PubMed |
| 40,991,409 | Harnessing fusion of genome-edited human stem cells to rapidly screen for novel protein functions in vivo. | Mol Biol Cell | 2025 | https://conductscience.org/library/papers/40991409 | PubMed |
| 38,893,223 | When DNA Mutations Interplay with Cellular Proliferation: A Narrative History of Theories of Carcinogenesis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893223 | PubMed |
| 38,853,931 | Single-nucleus multi-omic profiling of polyploid heart nuclei identifies fusion-derived cardiomyocytes in the human heart. | Res Sq | 2024 | https://conductscience.org/library/papers/38853931 | PubMed |
| 37,631,304 | Therapeutic Implications of PTEN in Non-Small Cell Lung Cancer. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631304 | PubMed |
| 37,565,737 | AF9 sustains glycolysis in colorectal cancer via H3K9ac-mediated PCK2 and FBP1 transcription. | Clin Transl Med | 2023 | https://conductscience.org/library/papers/37565737 | PubMed |
| 37,418,548 | Restoring tumor immunogenicity with dendritic cell reprogramming. | Sci Immunol | 2023 | https://conductscience.org/library/papers/37418548 | PubMed |
| 36,980,201 | Cellular Senescence, a Novel Area of Investigation for Metastatic Diseases. | Cells | 2023 | https://conductscience.org/library/papers/36980201 | PubMed |
| 35,527,376 | Hybrid/Atypical Forms of Circulating Tumor Cells: Current State of the Art. | Biochemistry (Mosc) | 2022 | https://conductscience.org/library/papers/35527376 | PubMed |
1 to 10 of 132
See all 132 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5387828
GET https://conductscience.org/api/papers/v1/5387828/cited_by?page=2